Table 2.

Joint Radiation/Chemotherapy Review

	All Patients						Patients starting Irinotecan						Patients not starting Irinotecan
	(n=152)						(n=95)						(n=57)
	Chemo Review						Chemo Review						Chemo Review
	Per Protocol		Not Per Protocol		Not Evaluable		Per Protocol		Not Per Protocol		Not Evaluable		Per Protocol		Not Per Protocol		Not Evaluable
	n	%	n	%	n	%	n	%	n	%	n	%	n	%	n	%	n	%
Per protocol	83	54	50	33	2	1	61	64	31	33	1	1	22	39	19	33	1	2
Acceptable variation	7	5	3	2	0	0	2	2	0	0	0	0	5	9	3	5	0	0
Unacceptable deviation	1	1	1	1	0	0	0	0	0	0	0	0	1	2	1	2	0	0
Incomplete RT (death during RT)	0	0	1	1	0	0	0	0	0	0	0	0	0	0	1	2	0	0
Incomplete RT (progression)	3	2	0	0	0	0	0	0	0	0	0	0	3	5	0	0	0	0
Incomplete RT (refusal)	0	0	1	1	0	0	0	0	0	0	0	0	0	0	1	2	0	0